The Consequences of Declining Vaccination Rates

The United States is relearning a lesson it spent decades trying to forget: vaccine-preventable disease does not stay gone simply because the public has grown accustomed to its absence. Measles was declared eliminated in 2000. Pertussis (Whooping Cough) had been pushed back by widespread childhood immunization. Once parents no longer saw children hospitalized with measles or infants struggling to breathe from whooping cough, the risk of the disease became less visible than the claims being made about the vaccine. The anti-vaccination movement filled that gap. It has persuaded more families to delay or refuse routine shots, weakened protection in vulnerable communities, and returned Washington to a fight over diseases the country already knows how to prevent.

The 2026 Measles Resurgence

The 2026 measles numbers have made the cost harder to dismiss. More than 2,700 cases were reported by late August, the highest level in roughly 35 years, and Pennsylvania recorded the first measles deaths of the year among unvaccinated residents. National kindergarten coverage for the measles, mumps, and rubella vaccine stood at 92.4 percent for the 2025-2026 school year, below the level generally needed to keep a virus this contagious from spreading. Outbreaks begin in counties, schools, congregations, and neighborhoods where vaccination rates fall far enough for one imported case to become dozens. Federal policy can set the direction, but local gaps determine whether the system holds.

Roots of the Anti-Vaccine Movement

Though it may seem that the anti-vaccine movement began with COVID-19, it instead rapidly grew after publication of a fraudulent 1998 paper that claimed a connection between the MMR vaccine and autism. The paper was retracted, its author lost his medical license, and the scientific claim was repeatedly disproved. By the time the record was corrected, the allegation had become a durable political story: public health officials knew less than they claimed, manufacturers could not be trusted, and caution required departing from the recommended schedule. COVID-19 gave that story a much larger audience. Anger over mandates and distrust of federal institutions spilled into routine pediatric care, where the evidence has been settled for years but public confidence no longer is.

The Administration's Vaccine Policy

The Administration has brought greater attention to vaccine policy and public concerns about vaccine safety. President Trump has publicly questioned aspects of the current vaccination schedule, including revisiting the long-debunked theory linking vaccines to autism, and has signed an executive order calling for the combined MMR vaccine to be administered as separate shots as soon as they are available in the United States. However, stand-alone measles, mumps, and rubella vaccines are not currently available in the United States. Pediatric practices are built around the existing schedule, and each additional appointment creates another opportunity for a child to miss a recommended dose. Public health experts have not identified a demonstrated benefit to extending the vaccination schedule in this way. Even so, continued discussion of these proposals at the federal level has contributed to renewed debate over vaccine policy despite longstanding scientific consensus supporting the current approach.

Vaccination as a Shared Responsibility

Washington often discusses vaccine policy as a dispute over personal choice. A parent may decide whether to vaccinate one child, but the result is shared by infants too young to receive a full series, cancer patients and transplant recipients whose immune systems cannot respond normally, and families whose children attend the same schools. Measles exposes the weakness in treating vaccination as a purely private decision because the virus is fast and indifferent to political boundaries. Once community protection falls, public health departments must trace contacts, schools must exclude exposed students, and hospitals must isolate patients. The cost of hesitation becomes a public expense.

Whooping Cough and the Cost of Hesitation

Whooping Cough receives less attention than measles, but the CDC reported 16 whooping cough-related deaths in 2025, including 10 infants younger than one year. The recent increase cannot be attributed to declining vaccination alone because pertussis follows cyclical patterns and protection from acellular vaccines wanes over time. When cases rise, pediatricians and health departments spend more time reaching out exposed families and determining who needs preventive treatment. That work receives little public attention, but healthcare organizations still have to pay the cost.

Congress and the Limits of Access

Congress has not abandoned immunization policy, but it has largely avoided a direct confrontation with the anti-vaccination movement. Federal lawmakers continue to fund the Vaccines for Children program, surveillance, preparedness, and state immunization infrastructure. Yet access is no longer the only problem. A fully stocked clinic does little good when families have been persuaded that following the schedule is dangerous. The next phase of federal policy will have to address both supply and trust. That means oversight of agency communications, clearer expectations for how HHS handles misinformation, and sustained support for local clinicians who remain the most credible messengers for many parents.

The Agencies That Will Decide

The agencies will matter more than any single congressional hearing. HHS will decide whether vaccine policy is presented as established public health practice or reopened as an ideological dispute. CDC and its advisory process will shape the schedule and the evidence supporting it. FDA will remain responsible for product safety and manufacturing questions, including any attempt to restructure combination vaccines. CMS can affect access through Medicaid, CHIP, and coverage requirements, while states will continue setting school-entry rules and exemption standards. Organizations should watch appointments, advisory committee membership, federal messaging, grant conditions, and the treatment of state outbreak data.

What Healthcare Organizations Should Plan For

Healthcare organizations should plan for a less predictable operating environment. Children's hospitals and pediatric practices should assume that localized outbreaks will require more staff time, more outreach, and harder conversations with families. Community health centers may face the same demands while serving patients with transportation barriers, language needs, and inconsistent records. Schools and employers will need exposure, exclusion, and return policies. Manufacturers will be watching whether federal recommendations remain stable enough to support long-term production planning. Insurers will see the downstream cost when preventable infections lead to emergency visits, hospitalizations, and public health interventions.

What the Next 12 to 24 Months Will Show

The next 12 to 24 months will show whether federal policy slows the decline or accelerates it. The indicators to watch will be vaccination rates, exemption trends, outbreak size, missed-dose patterns, and whether federal agencies give clinicians clear guidance or force them to navigate contradictory messages. Congress can use oversight and appropriations to reinforce evidence-based immunization policy, but implementation will occur through agency decisions and state systems. Public health departments, schools, pediatricians, manufacturers, payers, and community organizations will determine whether those decisions reach families in a usable form. The anti-vaccination movement has already made old diseases politically relevant again. Whether it makes them routinely common will depend on what those institutions do next.